Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
9. November 2023
3 min to read

Diagnostic Accuracy of a Smartphone Application for Artificial Intelligence-based Interpretation of 12-lead ECG in Primary Care (AMSTELHEART-1)

Overview:

Accurately interpreting 12-lead ECGs in primary care can be challenging for clinicians due to limited training, time constraints, and variability in expertise. This study validated the PMcardio Core AI ECG Model for AI-driven ECG analysis, demonstrating 86% sensitivity and 92% specificity for major abnormalities, along with near-perfect accuracy for atrial fibrillation, highlighting its potential to enhance early case detection.

Published In: European Heart Journal
Presented Date: November 9, 2023

Background

The use of 12-lead electrocardiogram (ECG) is common in routine primary care, however it can be difficult for less experienced ECG readers to adequately interpret the ECG.

We sought to validate a novel smartphone application as a stand-alone interpretation tool for 12-lead ECG in primary care.

Methods

We recruited consecutive patients who underwent 12-lead ECG as part of routinely indicated primary care in the Netherlands. All ECGs were assessed by a smartphone application that analyses a photographed image of a 12-lead ECG for automated interpretation, installed on an Android platform and an iOS platform.

We validated the application for detecting: 1) any major ECG abnormality (MEA, primary outcome) defined as atrial fibrillation/flutter (AF), markers of (past) myocardial ischemia or clinically relevant impulse and/or conduction abnormalities; or 2) AF (key secondary outcome). The reference standard was a blinded expert panel.

Results

We included 290 patients from 11 Dutch general practices with median age 67 (IQR 55-74) years, 48% were female. On reference ECG, 71 patients (25%) had MEA, 35 (12%) had AF. The app’s sensitivity and specificity for MEA were 86% (95%CI:76-93) and 92% (95%CI:87-95), respectively.

For AF, sensitivity and specificity were 97% (95%CI:85-100) and 99% (95%CI:97-100), respectively. Performance was comparable between Android and iOS platform (Kappa=0.95, 95%CI:0.91-0.99 and Kappa=1.00, 95%CI:1.00-1.00 for MEA and AF, respectively).

Conclusion

A smartphone application that interprets photographed 12-lead ECG images had good diagnostic accuracy in a primary care setting for major ECG abnormalities, and near-perfect properties for diagnosing AF.

Authors: J C L Himmelreich, R E Harskamp
 

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry

In a large, multi-center evaluation presented as Late-Breaking Science at the TCT 2025 conference, investigators assessed the diagnostic accuracy of the Queen of Hearts™ AI algorithm for ST-segment elevation myocardial infarction (STEMI) detection in emergency care. The study compared AI-enhanced ECG interpretation against standard triage protocols across three U.S. PCI centers, encompassing more than 1,000 patients who activated emergent reperfusion pathways. Published in JACC: Cardiovascular Interventions, the results demonstrated significantly improved accuracy and reduced false activations when using AI-driven analysis.

Electrocardiographic Diagnostic Possibilities for Atrial Fibrillation Using Artificial Intelligence: Differentiation from Sinus Rhythm and Other Arrhythmias with the Pmcardio App in Covid-19 Patients

This study evaluated how effectively artificial intelligence can detect atrial fibrillation (AF) in COVID-19 patients using ECG analysis. Researchers compared the PMcardio AI application’s performance with that of cardiologists and infectious disease specialists. Among 116 hospitalized COVID-19 patients, PMcardio achieved perfect diagnostic accuracy (sensitivity and specificity of 1.00) for AF detection, matching cardiologists and surpassing infectious disease specialists. The AI’s performance remained consistent across confidence levels, and its severity assessments correlated significantly with rhythm findings. These results highlight AI’s potential to improve arrhythmia detection, streamline care, and reduce unnecessary in-person evaluations during infectious disease outbreaks.

Join over 100,000 healthcare professionals who are already taking advantage of AI